Using the case study approach, we’ll address these questions and more in an interactive fashion:
- What are all the pathways to market and the advantages and disadvantages of each?
- How do I decide which one to use and when?
- If my device is class III, is the PMA my only option? If my device is class II, is the 510k my only option?
- How does the Breakthrough Devices Program (BDP) and Safer Technologies Program (STeP) affect pathway options?
- Can I market a device without any FDA oversight whatsoever?
- If someone else brought a similar device to market using one pathway, must I use the same pathway?
- Must I choose only one pathway? Can I use multiple pathways for the same device at the same time?
- How can I use label expansions to bring my device to market with less time, money and risk?
- How can I get my device on to the market and make it more difficult for my competitors at the same time?
- How do I integrate regulatory strategy with reimbursement strategy, product liability strategy, IP strategy, etc.?
Bottom line: not only are there multiple pathways to market but there advantages and disadvantages to each pathway one. You can combine them, mix and match them, do very interesting things with them… All examples of competitive regulatory strategy.
So, unless you understand all of the different possible pathways to market for your device — not just the most common ones – and the advantages and disadvantages to each, how can you decide when to use or not use each one? There are many more possibilities than most people think and learning how best to use them is creative regulatory strategy!
Who Should Attend?
- Medical Device Executives
- Regulatory Affairs Professionals and Management
- Quality Professionals and Management
- Clinical Affairs Professionals and Management
- R&D Engineers and Management